The FDA’s Alzheimer’s betrayal ...Middle East

On June 7, the Food and Drug Administration (FDA) approved a new drug from Biogen — Aduhelm — for the treatment of Alzheimer’s Disease after a gap of approximately 20 years since the last drug was approved to treat this terrible condition. The drug is an antibody that binds to the protein beta-amyloid, which is a biomarker of the disease. The approval was largely based on the ability of the drug to lower beta-amyloid levels in the brain, even though this phenomenon was not associated with discernible clinical improvement and early results were conflicting.

Read More Details
Finally We wish PressBee provided you with enough information of ( The FDA’s Alzheimer’s betrayal )

Also on site :

Thai Prime Minister Unites Coalition
Voices: ‘Worth every penny’ or ‘a bit OTT’? Readers debate the rise of expensive dog birthday parties
Yogandhra: A Celebration of Holistic Education Through Yoga

The FDA’s Alzheimer’s betrayal ...Middle East

Delhi Slum Dwellers Rally Against BJP's Demolition Drive

Amit Shah's Determined Stand Against Naxalism

US dealt Iran’s nukes a major blow — but here’s why the cheers may be premature

BJP Councillor's Son Arrested in Fatal Hit-and-Run Incident

Voices: English wine is having a moment… so which ones should you try first?

For a change, Primary Day won’t decide NYC’s next mayor

Trump and Netanyahu defied the diplomats — and saved the free world

Breakthrough Energy Discovery in Sindh: A New Hope for Pakistan's Energy Sector

SCOTUS’ trans ruling: Letters to the Editor — June 23, 2025

Trump’s support keeps growing while Democrats howl at the moon

Ensuring a Smooth and Safe Rath Yatra: Odisha's Preparations in Full Swing

Dalit Groom's Procession Sparks Clash in Thakur-Dominated Village

Latest: US inserts itself into Israel-Iran war, strikes 3 Iranian nuclear sites

Voices: I’m a business journalist – here’s why I’ll never activate my debit card

Hollywood and Obama should be judged for covering up Joe Biden’s frailty